Journal of Oncology and Cancer Research

Dr. Yongqiang Zhou is a cancer biologist and biomedical researcher affiliated with Lanzhou University, China. His work focuses on molecular and cellular mechanisms driving liver diseases, particularly hepatocellular carcinoma, fibrosis, and immune microenvironment modulation. He has authored multiple high-impact publications in journals such as Molecular Cancer, Cell Death and Disease, and The American Journal of Pathology. His research integrates molecular genetics, immunology, and systems biology to explore new therapeutic targets in liver regeneration and cancer progression.

• Liver fibrosis and regeneration
• Cancer stem cells and metastasis mechanisms
• Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma

1. Active researcher in oncology and molecular biology with an H-index of 18
2. Total publications: 9 (indexed in Web of Science)
3. Sum of citations: 181
4. Ongoing contribution to studies in hepatology and cancer biology
5. Likely involved in collaborative, translational research in molecular mechanisms of cancer

1. Tauroursodeoxycholic Acid Induces Liver Regeneration and Alleviates Fibrosis Through GATA3 Activation. Biomedicines, Apr 2025. DOI: 10.3390/BIOMEDICINES13040910

2. KAT7-acetylated YBX1 promotes hepatocellular carcinoma proliferation by reprogramming nucleotide metabolism. BMC Cancer, Feb 2025. DOI: 10.1186/S12885-025-13708-W

3. Modulating PCGF4/BMI1 Stability Is an Efficient Metastasis-Regulatory Strategy Used by Distinct Subtypes of Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma. The American Journal of Pathology, Jul 2024. DOI: 10.1016/J.AJPATH.2024.03.012

4. The m6A reader IGF2BP2 regulates glycolytic metabolism and mediates histone lactylation to enhance hepatic stellate cell activation and liver fibrosis. Cell Death and Disease, Mar 2024. DOI: 10.1038/S41419-024-06509-9

5. Tumor cell density-dependent IL-8 secretion induces fluctuation of Tregs/CD8+ T cell infiltration in hepatocellular carcinoma: one prompt for the existence of density checkpoint. Journal of Translational Medicine, Mar 2023. DOI: 10.1186/S12967-023-04060-3

6. NK cells are never alone: crosstalk and communication in tumour microenvironments. Molecular Cancer, Feb 2023. DOI: 10.1186/S12943-023-01737-7

7. Gly-tRF enhances LCSC-like properties and promotes HCC cell migration by targeting NDFIP2. Cancer Cell International, Sep 2021. DOI: 10.1186/S12935-021-02102-8

8. Loss of neuropilin 1 inhibits liver cancer stem cell population and blocks metastasis in hepatocellular carcinoma via epithelial-mesenchymal transition. Neoplasma, Mar 2021. DOI: 10.4149/NEO_2020_200914N982